RBC Bioscience Corporation (TPEX:6848)

Taiwan · Delayed Price · Currency is TWD

15.65

+0.70 (4.68%)

Apr 1, 2026, 12:00 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Manufacture and Sales of Reagents and Instruments	205.25M	172.47M	173.89M	251.18M	575.16M
Manufacture and Sales of Reagents and Instruments Growth	19.01%	-0.82%	-30.77%	-56.33%	255.74%
Total	205.25M	172.47M	173.89M	251.18M	575.16M
Total Growth	19.01%	-0.82%	-30.77%	-56.33%	255.74%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Europe	140.56M	112.03M	105.15M	148.20M	395.58M
Europe Growth	25.47%	6.54%	-29.05%	-62.54%	409.77%
Asia	23.93M	18.07M	19.66M	41.86M	83.47M
Asia Growth	32.47%	-8.12%	-53.02%	-49.85%	77.69%
Africa	13.99M	16.56M	10.27M	17.89M	19.54M
Africa Growth	-15.53%	61.26%	-42.58%	-8.45%	160.15%
Taiwan	13.83M	14.67M	20.01M	17.32M	23.71M
Taiwan Growth	-5.75%	-26.70%	15.54%	-26.94%	26.52%
America	12.83M	11.08M	18.79M	25.90M	51.95M
America Growth	15.81%	-41.04%	-27.44%	-50.15%	387.82%
Other	105.00K	65.00K	-	-	-
Other Growth	61.54%	-	-	-	-
Australia	-	-	6.00K	20.00K	927.00K
Australia Growth	-	-	-70.00%	-97.84%	339.34%
Total	205.25M	172.47M	173.89M	251.18M	575.16M
Total Growth	19.01%	-0.82%	-30.77%	-56.33%	255.74%

Source: S&P Global Market Intelligence.